These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21332939)

  • 1. Longitudinal study of painful diabetic neuropathy in the Zucker diabetic fatty rat model of type 2 diabetes: impaired basal G-protein activity appears to underpin marked morphine hyposensitivity at 6 months.
    Otto KJ; Wyse BD; Cabot PJ; Smith MT
    Pain Med; 2011 Mar; 12(3):437-50. PubMed ID: 21332939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats.
    Oltman CL; Coppey LJ; Gellett JS; Davidson EP; Lund DD; Yorek MA
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E113-22. PubMed ID: 15727946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin implants prevent the temporal development of mechanical allodynia and opioid hyposensitivity for 24-wks in streptozotocin (STZ)-diabetic Wistar rats.
    Otto KJ; Wyse BD; Cabot PJ; Smith MT
    Pain Med; 2011 May; 12(5):782-93. PubMed ID: 21481170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats.
    Shimoshige Y; Ikuma K; Yamamoto T; Takakura S; Kawamura I; Seki J; Mutoh S; Goto T
    Metabolism; 2000 Nov; 49(11):1395-9. PubMed ID: 11092500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
    Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
    Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the gene expression of specific G-protein subunits correlate with morphine insensitivity in streptozotocin-induced diabetic rats.
    Hajializadeh Z; Esmaeili-Mahani S; Sheibani V; Kaeidi A; Atapour M; Abbasnejad M
    Neuropeptides; 2010 Aug; 44(4):299-304. PubMed ID: 20334911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia.
    Sugimoto K; Rashid IB; Kojima K; Shoji M; Tanabe J; Tamasawa N; Suda T; Yasujima M
    Diabetes Metab Res Rev; 2008; 24(8):642-50. PubMed ID: 18973207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats.
    Dyrskog SE; Jeppesen PB; Colombo M; Abudula R; Hermansen K
    Metabolism; 2005 Sep; 54(9):1181-8. PubMed ID: 16125530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat--role of food intake and corticosterone.
    Bates HE; Kiraly MA; Yue JT; Goche Montes D; Elliott ME; Riddell MC; Matthews SG; Vranic M
    Metabolism; 2007 Aug; 56(8):1065-75. PubMed ID: 17618951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise.
    Király MA; Bates HE; Yue JT; Goche-Montes D; Fediuc S; Park E; Matthews SG; Vranic M; Riddell MC
    Metabolism; 2007 Jun; 56(6):732-44. PubMed ID: 17512304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment.
    Pickavance L; Widdowson PS; King P; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Oct; 125(4):767-70. PubMed ID: 9831913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
    van Poelje PD; Potter SC; Chandramouli VC; Landau BR; Dang Q; Erion MD
    Diabetes; 2006 Jun; 55(6):1747-54. PubMed ID: 16731838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural, morphological and electrophysiological assessment of the effects of type 2 diabetes mellitus on large and small nerve fibres in Zucker diabetic fatty, Zucker lean and Wistar rats.
    Garcia-Perez E; Schönberger T; Sumalla M; Stierstorfer B; Solà R; Doods H; Serra J; Gorodetskaya N
    Eur J Pain; 2018 Sep; 22(8):1457-1472. PubMed ID: 29676840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserved LTP and water maze learning in hyperglycaemic-hyperinsulinemic ZDF rats.
    Bélanger A; Lavoie N; Trudeau F; Massicotte G; Gagnon S
    Physiol Behav; 2004 Dec; 83(3):483-94. PubMed ID: 15581671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet selection improves morphine's antinociceptive actions in rats with streptozotocin-induced diabetes.
    Leibovici M; Kanarek RB
    Behav Neurosci; 2007 Oct; 121(5):965-75. PubMed ID: 17907828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
    Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
    Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired skin microvascular reactivity in painful diabetic neuropathy.
    Quattrini C; Harris ND; Malik RA; Tesfaye S
    Diabetes Care; 2007 Mar; 30(3):655-9. PubMed ID: 17327336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats.
    Suh YH; Kim Y; Bang JH; Choi KS; Lee JW; Kim WH; Oh TJ; An S; Jung MH
    J Mol Endocrinol; 2005 Apr; 34(2):299-315. PubMed ID: 15821098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
    Ueta K; Ishihara T; Matsumoto Y; Oku A; Nawano M; Fujita T; Saito A; Arakawa K
    Life Sci; 2005 Apr; 76(23):2655-68. PubMed ID: 15792833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.